Parameter | Unit | Estimate (CV%) | Comment | Drug-specific? | ||
---|---|---|---|---|---|---|
Protein interactions model | \( {\mathrm{k}}_{\deg_{\mathrm{i}}} \) | Synthesis- or degradation rate constant for the turnover of protein i. (protein-specific parameters) | h−1 | 0.649 (16.8) | Bcl2, cIAP1 and pNF-κB (pp65) | N |
0.127 (6.94) | IRAK4 | N | ||||
8.26 × 10− 3 (38.9) | pJNK | N | ||||
3.16 × 10−2 (46.7) | pSTAT3 | N | ||||
0.696 (165) | VDAC1 | N | ||||
2.80 × 10−2 (9.39) | ELYS | N | ||||
0.861 (39.3) | ASPP2 | N | ||||
2.91 × 10−2 (7.41) | BAX | N | ||||
γi-j | Power coefficient for an interaction when the synthesis rate of protein i is modified by protein j. (protein-specific parameters) | – | −0.298 (9.31) | pNF-κB |- cIAP1 | N | |
1.85 (11.0) | BAX < - pNF-κB | N | ||||
0.768 (8.36) | BCL2 < - pNF-κB | N | ||||
1.0 (−a) | pSTAT3 < − IRAK4 VDAC1 < - pJNK ASPP2 < - ELYS | N | ||||
1.33 (20.9) | BCL2 < - pSTAT3 | N | ||||
−4.16 (8.38) | BCL2 |- VDAC1 | N | ||||
−2.30 (30.3) | pSTAT3 |- pJNK | N | ||||
−9.55 (16.2) | BAX |- BAX | N | ||||
−6.10 (12.6) | ELYS |- ELYS | N | ||||
Ei_x | Effect of treatment x on the synthesis rate of protein i (drug-specific parameters) | – | 0.960 (1.76) | IRAK4 < - B/P/B + P (StiX) | Y | |
−0.967 (0.503) | cIAP1 |- B (InhB) | Y | ||||
2.22 (12.2) | ELYS <- P (StiP) | Y | ||||
1.0b (−a) | pJNK <− B + P (InhB + P) | Y | ||||
Cell cycle and apoptosis | kxx | The 1st-order transition rate constant between cell cycle phases or apoptosis stages (cell-specific) | h−1 | 4.48 × 10−2 (8.60) | G0/G1 to S (k12) | N |
0.129 (7.25) | S to G2/M (k23) | N | ||||
8.07 × 10−2 (5.78) | G2/M to G0/G1 (k31) | N | ||||
2.18 × 10−3 (15.6) | Live to apoptotic (kap) in the absence of treatment | N | ||||
1.97 × 10−2 (0.938) | Mitosis-arrested to polyploid (kpl) | N | ||||
Nmax | The capacity of cell density | – | 7.43 (14.6) | Fold increase compared to seeding density in 6-well plates | N | |
live0 | The cell number at the beginning of the study | 2.0 × 105 (fixed) | Seeding density in 6-well plates | N | ||
Integrated protein-based cell cycle and apoptosis | kxx | The transition rate constant between cell cycle phases or apoptosis stages (cell-specific) | h−1 | 2.39 × 10−2 (2.01) | Normal G2/M to mitotic arrested (kma0) | N |
0.111 (8.22) | Mitotic arrested to apoptosis (kapm0) | N | ||||
γi | Power coefficient for protein i to modify a transition rate constant (protein-specific) | – | −0.532 (0.81) | cIAP1 inhibits kap | N | |
−7.72 × 10−2 (13.7) | cIAP1 inhibits kapm0 | N | ||||
0.208 (45.8) | BAX stimulates kapm0 | N | ||||
3 (−a) | ELYS stimulates kar | N |